Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem Cell Transplantation: An Ancillary Analysis of a Randomized Controlled Trial Comparing Tacrolimus/Sirolimus and Tacrolimus/Methotrexate (Blood and Marrow Transplant Clinical Trials Network/BMT CTN 0402)-Reference-Cited by-同舟云学术

Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem Cell Transplantation: An Ancillary Analysis of a Randomized Controlled Trial Comparing Tacrolimus/Sirolimus and Tacrolimus/Methotrexate (Blood and Marrow Transplant Clinical Trials Network/BMT CTN 0402)

Published:2019-11 Issue:11 Volume:25 Page:2143-2151
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Gooptu Mahasweta,Kim Haesook T.,Howard Alan,Choi Sung W.,Soiffer Robert J.,Antin Joseph H.,Ritz Jerome,Cutler Corey S.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference21 articles.

1. Pathophysiology of chronic graft-versus-host disease and therapeutic targets;Zeiser;N Engl J Med,2017

2. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors;Nash;Blood,2000

3. Sirolimus: its discovery, biological properties, and mechanism of action;Sehgal;Transplant Proc,2003

4. Tacrolimus (FK506) and sirolimus (rapamycin) in combination are not antagonistic but produce extended graft survival in cardiac transplantation in the rat;Vu;Transplantation,1997

5. Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation;Antin;Blood,2003

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Joint models quantify associations between immune cell kinetics and allo-immunological events after allogeneic stem cell transplantation and subsequent donor lymphocyte infusion;Frontiers in Immunology;2023-08-01

2. Effect of mTOR Inhibition with Sirolimus on Natural Killer Cell Reconstitution in Allogeneic Stem Cell Transplantation;Transplantation and Cellular Therapy;2023-06

3. Regulatory T cells as a therapeutic approach for inflammatory bowel disease;European Journal of Immunology;2023-01-06

4. Predictors and outcomes of dose reduction of methotrexate and cyclosporin graft‐versus‐host disease prophylaxis following allogeneic haemopoietic cell transplantation;Internal Medicine Journal;2022-09-06

5. Simultaneous Determination of Six Immunosuppressants in Human Whole Blood by HPLC-MS/MS Using a Modified QuEChERS Method;Molecules;2022-06-25